CTOs on the Move

Erytech

www.erytech.com

 
ERYTECH is a clinical-stage biopharmaceutical company developing innovative red blood cell-based therapeutics to treat severe forms of cancer and orphan diseases. Leveraging its proprietary ERYCAPS® platform, which uses a novel technology to encapsulate drug substances inside red blood cells, ERYTECH is developing a pipeline of product candidates for patients with high unmet medical needs. ERYTECH`s primary focus is on the development of product candidates that target the altered metabolism of cancer cells by depriving them of amino acids necessary for their growth and survival. The Company`s lead product candidate, eryaspase, which consists of L-asparaginase encapsulated inside donor-derived red blood cells, ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.erytech.com
  • 1 Main Street Suite 300
    Cambridge, MA USA 02142
  • Phone: 857.706.1585

Executives

Name Title Contact Details
Stewart Craig
Chief Technology Officer Profile
Stewart Craig
Chief Technology Officer Profile

Similar Companies

OnSite Waste Technologies

Save time, money and resources with the smarter, simpler, and safer way to handle regulated medical waste

Evergreen Theragnostics

Evergreen Theragnostics was established in 2019 to be a leading US-based radiopharmaceutical Contract Development and Manufacturing Organization (CDMO).

Jennerex Biotherapeutics

Jennerex Biotherapeutics is a San Francisco, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Chemrx

Chemrx is a South Plainfield, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

CannaPharmaRx

Headquartered in Carney's Point, New Jersey, CannaPharmaRx is a pharmaceutical company whose mission is to advance cannabinoid discovery, science, research & development, and to bring novel prescription, veterinary and personal care cannabinoid-based products to market in the U.S. and worldwide.